Impact of limited cephalosporin use on prevalence of methicillin-resistant Staphylococcus aureus in the intensive care unit

Journal of Chemotherapy

Volumn 21, Issue 6, 2009, Pages 633-638

  Bassetti, Matteo ^a   Righi, E ^a   Ansaldi, F ^a   Molinari, M P ^a   Rebesco, B ^a   Mcdermott, J L ^a   Fasce, R ^a   Mussap, M ^a   Icardi, G ^a   Bobbio Pallavicini, F ^a   Viscoli, C ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antibiotics; Cephalosporins; ICU; K. pneumoniae; MRSA; P. Aeruginosa; Restriction

Indexed keywords

CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CORRELATION ANALYSIS; DRUG USE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; PREVALENCE; PSEUDOMONAS AERUGINOSA; TREND STUDY; CLINICAL TRIAL; CROSS INFECTION; DRUG EFFECT; INFECTION CONTROL; METHODOLOGY; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; KLEBSIELLA PNEUMONIAE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCAL INFECTIONS;

EID: 77649304231     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2009.21.6.633     Document Type: Article

References (23)

1. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Tolson JS, Martone WJ. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol. 1992;13:582-6.
2. Meyer E, Schwab F, Gastmeier P, Jonas D, Rueden H, Daschner FD. Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units). Infect Control Hosp Epidemiol 2006;27:146-54.
3. Lodise TP Jr, McKinnon PS, Rybak M. Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance. Infect Control Hosp Epidemiol. 2003;24:655-61.
4. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001;39:3727-32.
5. 2006 European Antimicrobial Resistance Surveillance System. EARSS annual report 2006. Bilthoven, The Netherlands, 2007.
6. Herwaldt LA. Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am J Med 1999;106:11S-18S.
7. Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA. Methicillin resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313-28.
8. Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Med 2006;119:S11-S19.
9. Monnet DL, MacKenzie FM, Lopez-Lozano JM et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004; 10:1432-41.
10. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999;28:1062.
11. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002;49:999-1005.
12. Harbarth S, Liassine N, Dharan S, Herrault P, Auckenrhaler R, Pittet D. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2000;31:1380-5.
13. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003;9:1415-22.
14. Raymond DP, Pelletier SJ, Crabtree TD et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001;29:1103-1108.
15. Madaras-Kelly KJ, Remington RE, Lewis PG, Stevens DL. Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol 2006;27:155-69.
16. World Health Organization collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification index with defined daily doses (DDDs). Oslo, Norway: The Center 2001.
17. Stone SP, Cooper BS, Kibbler CC, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis. 2007;7:282-8.
18. Carmeli Y, Castro J, Eliopoulos GM, Samore MH. Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam. Antimicrob Agents Chemother 2001; 45: 275-9.
19. Hill DA, Herford T, Parratt D. Antibiotic usage and methicillin-resistant Staphylococcus aureus: an analysis of causality. J Antimicrob Chemother 1998;42:676-7.
20. Crowcroft NS, Ronveaux O, Monnet DL, Mertens R. Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol 1999; 20: 31-6.
21. Campillo B, Dupeyron C, Richardet JP. Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 2001 ;127: 443-50.
22. Dziekan G, Hahn A, Thune K Schwarzer G, Schafer K, Daschner FD, et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 2000; 46: 263-70.
23. Bassetti M, Cruciani M, Righi E , Rebesco B, Fasce R, Costa A, et al. Antimicrobial use and resistance among gramnegative bacilli in an Italian Intensive Care Unit (ICU). J Chemother 2006;18;261-267.